Metabolic engineering of Corynebacterium glutamicum for production of glutamate derivatives
Year: 2016
Type: dissertation
Abstract: The identification of Corynebacterium glutamicum as a glutamate producer in the\n1950’s was the start of its career as an amino acid producer. C. glutamicum has now been employed\nas cell factory for industrial amino acid production for over five decades and has a market size to\nreach $20 billion by 2020. As C. glutamicum was isolated for its natural ability to produce\nglutamate it makes it an excellent chassis for engineering it to produce its derivatives ornithine,\nproline, putrescine, citrulline, and arginine. These products are becoming increasingly important as\nthey have a wide range of applications and the demand for these products is rising. The construction\nof a platform strain can reduce the time and resources required for strain development. Another\napproach to reduce the time and resources required for strain development is by developing new\ntools for metabolic engineering. These strategies were both explored to ease the process of strain\nconstruction.\nProline, citrulline, and putrescine can be synthesized directly from ornithine, and three more\nreactions are required to synthesize arginine. Hence a strain engineered to produce ornithine can\nserve as a platform to produce the other four compounds. The first step was to establish proline and\ncitrulline production by C. glutamicum as the rational engineering of C. glutamicum for production\nof these two amino acids had not previously been described.\nProline is synthesized from glutamate via the proline biosynthetic pathway in most microorganisms,\nbut with the help of the enzyme ornithine cyclodeaminase (Ocd) it can be synthesized from\nornithine. Overexpression of putative ocd from C. glutamicum in an ornithine overproducing strain\ndid not result in detectable proline production. Plasmid-based expression of ocd from Pseudomonas\nputida (ocdPp) on the other hand allowed accumulation of proline with a yield of 0.06 g proline / g\nglucose (g pro/g glc). Interestingly replacing the stop codon TGA of ocdPp with TAA resulted in a\nremarkable decrease in glutamate accumulation while the yield of proline increased to 0.25 g pro/g\nglc. The byproduct accumulation was further reduced by medium optimization, which also entailed\na 25% higher proline yield. Lastly, the yield was boosted by overexpression of argBfbr encoding\nfeedback-alleviated N-acetylglutamate kinase to 0.36 ± 0.01 g pro/g glc.\nA base strain suitable for the production of ornithine, proline, putrescine, citrulline, and arginine\nwas constructed by deleting the repressor of the arginine pathway ArgR. Additionally the genes\nencoding enzymes of the arginine biosynthetic pathway were deleted, the deletion of argF allows\nornithine to accumulate, and the deletion of argG allows citrulline to accumulate when argF is\noverexpressed. To add citrulline to the product spectrum of the platform strain we found it\nnecessary to overexpress argBfbr along with argF. The strain accumulated citrulline with a yield of\n0.38 ± 0.01 g citrulline / g glucose. The potential and versatility of the strain was demonstrated by\nproducing citrulline from the alternative carbon sources starch, xylose, and glucosamine.\nAfter the product range of the base strain had been extended to include citrulline, metabolic\nengineering was performed to increase the ornithine yield of the strain. The initial assumption was\nthat an increased ornithine yield could be translated into increased yields of the other four bioproducts. The ornithine yield was improved by 71% with a yield of 0.52 g ornithine / g glucose\n(g orn/g glc) compared to 0.31 g orn/g glc of the parent strain. This was achieved by feedback\nalleviation of N-acetylglutamate kinase, tuning of the promoter of gdh encoding glutamate\ndehydrogenase, lowering expression of pgi encoding phosphoglucoisomerase, along with the\nintroduction of a second copy of the arginine biosynthetic operon argCJBfbrD into the chromosome.\nStrains capable of efficiently producing citrulline, proline, arginine or putrescine were derived from\nornithine producing strains by plasmid-based overexpression of appropriate pathway modules with\none to three genes. It was found that optimizing the base strain for ornithine production did not\nincrease citrulline and arginine yields any further, indicating that the reaction converting ornithine\ninto to citrulline is a bottleneck in citrulline and arginine production.\nFinally the popular CRISPR/dCas9 technology was adapted for the use of metabolic engineering in\nC. glutamicum. The system could be used to reversibly perturb gene expression. As proof of\nconcept we targeted pgi in the lysine overproducing strain DM1729, where an almost complete\nrepression of the transcription of the gene resulted in a 2-fold increase in the lysine titer. We also\ntargeted the genes pck and pyk to increase glutamate production in wild-type C. glutamicum where\nwe also observed nearly complete repression and increased glutamate titers.\nWith this work it was shown how valuable the concept of using a platform strain for production of\nseveral industrially relevant bioproducts is. Moreover an efficient way to screen for new targets for\nmetabolic engineering in C. glutamicum was demonstrated. From the initial cloning in Escherichia\ncoli the C. glutamicum clones could be obtained in as little as four days by adapting the\nCRISPR/dCas9 system.
Author: Jaide V K Jensen
Institution: Bielefeld University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2344199184
